DK165839C - Tigogenin-cellobiosidforbindelser, farmaceutiske praeparater, der indeholder forbindelserne, anvendelse af forbindelserne til fremstilling af et farmaceutisk praeparat samt fremgangsmaade til fremstilling af forbindelserne - Google Patents

Tigogenin-cellobiosidforbindelser, farmaceutiske praeparater, der indeholder forbindelserne, anvendelse af forbindelserne til fremstilling af et farmaceutisk praeparat samt fremgangsmaade til fremstilling af forbindelserne

Info

Publication number
DK165839C
DK165839C DK361084A DK361084A DK165839C DK 165839 C DK165839 C DK 165839C DK 361084 A DK361084 A DK 361084A DK 361084 A DK361084 A DK 361084A DK 165839 C DK165839 C DK 165839C
Authority
DK
Denmark
Prior art keywords
preparation
compounds
pharmaceutical
procedure
tigogenin cellobioside
Prior art date
Application number
DK361084A
Other languages
Danish (da)
English (en)
Other versions
DK361084A (da
DK361084D0 (da
DK165839B (da
Inventor
M Rene Malinow
Original Assignee
Oregon Medical Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Medical Res Found filed Critical Oregon Medical Res Found
Publication of DK361084D0 publication Critical patent/DK361084D0/da
Publication of DK361084A publication Critical patent/DK361084A/da
Publication of DK165839B publication Critical patent/DK165839B/da
Application granted granted Critical
Publication of DK165839C publication Critical patent/DK165839C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0015—Details of inhalators; Constructional features thereof with inhalation check valves located upstream of the dispenser, i.e. not traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Cephalosporin Compounds (AREA)
DK361084A 1984-04-20 1984-07-23 Tigogenin-cellobiosidforbindelser, farmaceutiske praeparater, der indeholder forbindelserne, anvendelse af forbindelserne til fremstilling af et farmaceutisk praeparat samt fremgangsmaade til fremstilling af forbindelserne DK165839C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60229884 1984-04-20
US06/602,298 US4602005A (en) 1982-05-17 1984-04-20 Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis

Publications (4)

Publication Number Publication Date
DK361084D0 DK361084D0 (da) 1984-07-23
DK361084A DK361084A (da) 1985-10-21
DK165839B DK165839B (da) 1993-01-25
DK165839C true DK165839C (da) 1993-06-21

Family

ID=24410793

Family Applications (2)

Application Number Title Priority Date Filing Date
DK361084A DK165839C (da) 1984-04-20 1984-07-23 Tigogenin-cellobiosidforbindelser, farmaceutiske praeparater, der indeholder forbindelserne, anvendelse af forbindelserne til fremstilling af et farmaceutisk praeparat samt fremgangsmaade til fremstilling af forbindelserne
DK014892A DK166213C (da) 1984-04-20 1992-02-06 Tigogenin-cellobiosid-heptaacetatforbindelser og fremgangsmaade til fremstilling heraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK014892A DK166213C (da) 1984-04-20 1992-02-06 Tigogenin-cellobiosid-heptaacetatforbindelser og fremgangsmaade til fremstilling heraf

Country Status (16)

Country Link
US (1) US4602005A (index.php)
EP (1) EP0159431B1 (index.php)
JP (1) JPS60224697A (index.php)
KR (1) KR940002114B1 (index.php)
AT (1) ATE42959T1 (index.php)
AU (1) AU580005B2 (index.php)
CA (1) CA1246544A (index.php)
DE (1) DE3478114D1 (index.php)
DK (2) DK165839C (index.php)
ES (1) ES534553A0 (index.php)
FI (2) FI82253C (index.php)
HU (1) HUT37802A (index.php)
IE (1) IE58015B1 (index.php)
NO (1) NO842990L (index.php)
NZ (1) NZ208961A (index.php)
ZA (1) ZA845690B (index.php)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4865850A (en) * 1986-09-08 1989-09-12 See/Shell Biotechnology, Inc. Dietary fat reduction
US5010185A (en) * 1989-06-13 1991-04-23 Pfizer Inc. Processes for tigogenin beta-cellobioside
US5091192A (en) * 1990-01-16 1992-02-25 Natur-All Systems, Inc. Bile salts permanently bound to insoluble cellulose as a dietary supplement
CA2079544A1 (en) * 1991-10-04 1993-04-05 Adam Weislaw Mazur Cholesterol lowering compounds
DE69225233T2 (de) * 1991-10-04 1998-11-19 Procter & Gamble Cholesterinsenkende Verbindungen und Verfahren zu ihrer Herstellung
HUT67035A (en) * 1991-11-25 1995-01-30 Pfizer New process for the production of steroidal glycosides derivatives
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
HUT68885A (en) * 1992-06-26 1995-08-28 Pfizer New process for steroidal peracyl glycosides
CA2138016A1 (en) * 1992-06-26 1994-01-06 Kathleen D. Goggin Steroidal beta-o-cellobioside heptaalkanoate process
AU4226593A (en) * 1992-06-26 1994-01-24 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
EP0696292A1 (en) * 1993-04-28 1996-02-14 Pfizer Inc. Spirostanyl glycosidal crystalline monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
WO1995000158A1 (en) * 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides
US5607841A (en) * 1994-06-20 1997-03-04 Lipinski; Boguslaw Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen
EP0782451A1 (en) * 1994-09-20 1997-07-09 Pfizer Inc. Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
WO1996038466A1 (en) * 1995-05-29 1996-12-05 Pfizer Inc. Steroidal glycosides
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
ID26989A (id) * 1998-03-26 2001-02-22 Phytopharm Plc Smilagenin dan anzurogenin-d untuk pengobatan penyakit alzheimer
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
AR032403A1 (es) * 2001-01-26 2003-11-05 Schering Corp Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares
DE60212801T2 (de) * 2001-01-26 2007-02-01 Schering Corp. Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
MXPA03006724A (es) * 2001-01-26 2003-10-24 Schering Corp Combinaciones de inhibidor(es) de absorcion de esterol con agente(s) cardiovascular(es) para el tratamiento de condiciones vasculares.
EP1671650A1 (en) * 2001-01-26 2006-06-21 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
HUP0303915A3 (en) * 2001-01-26 2012-12-28 Merck Sharp & Dohme Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
PT1363668E (pt) * 2001-01-26 2007-11-07 Schering Corp Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
AU2002308778A1 (en) * 2001-05-25 2002-12-09 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
ES2312624T3 (es) * 2001-09-21 2009-03-01 Schering Corporation Metodos para tratar o prevenir la inflamacion vascular usando un inhibidor (inhibidores) de la absorcion de esterol.
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
US7560449B2 (en) * 2002-11-06 2009-07-14 Schering Corporation Methods and therapeutic combinations for the treatment of demyelination
CN1756756A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
AU2003300732A1 (en) * 2003-12-31 2005-07-21 Council Of Scientific And Industrial Research Isolation of tigogenin pentaglycoside from chlorophytum nimonii
US7160866B2 (en) 2004-03-22 2007-01-09 Council Of Scientific And Industrial Research Isolation of tigogenin pentaglycoside from Chlorophytum nimonii

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
US4242502A (en) * 1979-04-20 1980-12-30 United States Of America Enhancement of cholesterol combining properties of saponins
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
DK361084A (da) 1985-10-21
EP0159431A3 (en) 1986-01-08
EP0159431B1 (en) 1989-05-10
DK361084D0 (da) 1984-07-23
JPH0456840B2 (index.php) 1992-09-09
JPS60224697A (ja) 1985-11-09
NZ208961A (en) 1988-01-08
DK166213C (da) 1993-08-16
KR940002114B1 (ko) 1994-03-17
DK14892A (da) 1992-02-06
FI842935L (fi) 1985-10-21
US4602005A (en) 1986-07-22
HUT37802A (en) 1986-02-28
EP0159431A2 (en) 1985-10-30
FI82253C (fi) 1991-02-11
DK165839B (da) 1993-01-25
FI87792C (fi) 1993-02-25
FI82253B (fi) 1990-10-31
KR850007432A (ko) 1985-12-04
ZA845690B (en) 1986-03-26
ATE42959T1 (de) 1989-05-15
IE841904L (en) 1985-10-20
NO842990L (no) 1985-10-21
DK166213B (da) 1993-03-22
ES8601233A1 (es) 1985-11-16
DE3478114D1 (en) 1989-06-15
CA1246544A (en) 1988-12-13
FI842935A0 (fi) 1984-07-23
ES534553A0 (es) 1985-11-16
IE58015B1 (en) 1993-06-16
FI900531A0 (fi) 1990-02-02
FI87792B (fi) 1992-11-13
AU3097784A (en) 1985-10-24
AU580005B2 (en) 1988-12-22
DK14892D0 (da) 1992-02-06

Similar Documents

Publication Publication Date Title
DK165839C (da) Tigogenin-cellobiosidforbindelser, farmaceutiske praeparater, der indeholder forbindelserne, anvendelse af forbindelserne til fremstilling af et farmaceutisk praeparat samt fremgangsmaade til fremstilling af forbindelserne
PT88603A (pt) Immunomodulatory azapiranes
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
ES8706717A1 (es) Metodo de preparar esteroides
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES2008109B3 (es) Procedimiento de preparacion de aminoalcoholes y de composiciones farmaceuticas que los contienen.
AU4566285A (en) Nitrogen containing heterocyclic compounds
ATE131061T1 (de) Förderung der osteogenese durch verwendung von vitamin d-derivaten.
FI96856C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi
MY100602A (en) Substituted spiro pyridine derivatives, pharmaceutical composition containing them and processes for the preparation of such compounds and compositions
DK56687D0 (da) 5-substitueret octahydroindolizinforbindelser samt 7-ketomellemprodukter ved fremstillingen heraf
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
MX9203180A (es) Derivados isosazolicos y composicion farmaceutica que los contiene.
MY103521A (en) Bicyclocatechol derivatives
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
FI850401A0 (fi) Maettade tricykliska kvaevehaltiga dioner saosom medel foer aktivering av fattningsfoeremaogan.
JPS5649360A (en) 2-oxoquinoline derivative
DK209284D0 (da) Dihydropyridiner,farmaceutiske kompositioner indeholdende disse,fremgangsmaade til forbindelsernes fremstilling og mellemprodukter anvendelige ved denne fremgangsmaade
FR2564904B1 (fr) Dispositif statique ameliorant la vaporisation du melange sortant des carburateurs
IT7867221A0 (it) Procedimento per la preparazione di composti azotati utilizzabili particolarmente come ritardatori di fiamma

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed